OPEN APP
Home / Science / Health /  A chronic disease still waiting for a drug

A chronic disease still waiting for a drug

These are just a few names among many companies conducting clinical trials with the hope of finding a drug that can reduce liver inflammation as well as fibrosis, a type of scarring that can lead to liver complications like cirrhosis (Photo: Bloomberg)Premium
These are just a few names among many companies conducting clinical trials with the hope of finding a drug that can reduce liver inflammation as well as fibrosis, a type of scarring that can lead to liver complications like cirrhosis (Photo: Bloomberg)
wsj

As biotech companies take new shots at fatty liver disease, investor skepticism and potential payoffs are high

Drug companies have developed treatments for some of the rarest diseases afflicting a tiny percentage of the population, yet they have failed repeatedly to get a drug on the market for a chronic and increasingly common one.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout